Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1951
Source ID: NCT00160160
Associated Drug: Eprosartan/Hctz
Title: Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Hypertension|Type 2 Diabetes
Interventions: DRUG: eprosartan/HCTZ
Outcome Measures: Primary: Blood pressure reduction | Secondary: Comparison of responder rates
Sponsor/Collaborators: Sponsor: Solvay Pharmaceuticals
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 440
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2004-10
Completion Date:
Results First Posted:
Last Update Posted: 2009-01-30
Locations: Site 26, Calgary, Canada|Site 27, Montreal, Canada|Site 30, Quebec, Canada|Site 31, Thornhill, Canada|Site 28, Vancouver, Canada|Site 29, Winnipeg, Canada|Site 39, Holbaek, Denmark|Site 38, Roskilde, Denmark|Site 40, Viborg, Denmark|Site 4, Anzin, France|Site 3, Blois, France|Site 10, Chemellier, France|Site 11, Cholet, France|Site 15, Cholet, France|Site 16, Cholet, France|Site 14, La Jubaudiere, France|Site 13, Le Mesnil-en-Vallee, France|Site 7, Murs-Erigne, France|Site 9, Saumur, France|Site 8, Segre, France|Site 12, St Pierre Montlim, France|Site 6, Thouars, France|Site 2, Tours, France|Site 5, Vieux Conde, France|Site 20, Bad Muenster, Germany|Site 22, Floersheim, Germany|Site 19, Kirweiler, Germany|Site 21, Lambrecht, Germany|Site 25, Lindau, Germany|Site 18, Lueneburg, Germany|Site 24, Lutherstadt, Germany|Site 17, Riesa, Germany|Site 23, Waldbrunn, Germany|Site 62, Bologna, Italy|Site 60, Napoli, Italy|Site 58, Padova, Italy|Site 59, Palermo, Italy|Site 63, Pavia, Italy|Site 61, Pisa, Italy|Site 64, Torino, Italy|Site 43, Alesund, Norway|Site 42, Bergen, Norway|Site 44, Horten, Norway|Site 41, Skedsmokorset, Norway|Site 55, Badajoz, Spain|Site 51, Badalona, Spain|Site 56, Barcelona, Spain|Site 57, Barcelona, Spain|Site 54, Ciudad Real, Spain|Site 53, Granada, Spain|Site 52, Madrid, Spain|Site 48, Angelholm, Sweden|Site 47, Goteburg, Sweden|Site 46, Helsingborg, Sweden|Site 45, Kristianstat, Sweden|Site 50, Malmo, Sweden|Site 49, Stockholm, Sweden|Site 33, Aberdeen, United Kingdom|Site 36, Bath, United Kingdom|Site 37, Liverpool, United Kingdom|Site 34, Manchester, United Kingdom|Site 32, Oldham, United Kingdom|Site 35, Rugby, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00160160

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D252 Eprosartan small molecule DB00876 Details
D296 Hydrochlorothiazide small molecule DB00999 Details